Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.66 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | ATM | Q13315 | 1/20 | 0.59 |
| ▸ | MDM4 | O15151 | 1/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29434803 | 1.00 | ALDH1A1 (0.66) | ALDH1A1ABCG2KMT2AMEN1TSHR | |
| Ammonia Solution, Strong SCHEMBL29194251 | 0.98 | ALDH1A1 (0.64) | ALDH1A1ABCG2KMT2AMEN1TSHR | |
| SCHEMBL10144027 | 0.91 | ALDH1A1 (0.74) | ALDH1A1ABCG2KMT2AMEN1TSHR | |
| SCHEMBL29020526 | 0.90 | MDM4 (0.67) | ALDH1A1ABCG2KMT2AMEN1MAPT | |
| Propanol SCHEMBL28052966 | 0.90 | ALDH1A1 (0.62) | ALDH1A1ABCG2KMT2AMEN1MAPT | |
| Acrylic Acid SCHEMBL1505000 | 0.90 | ALDH1A1 (0.57) | ALDH1A1ABCG2KMT2AMEN1TSHR | |
| SCHEMBL6067716 | 0.90 | HDAC1 (0.66) | ABCG2KMT2AMEN1MAPTHPGD | |
| SCHEMBL6059859 | 0.88 | KMT2A (0.64) | ALDH1A1KMT2AMEN1MAPTKDM4E | |
| SCHEMBL28442225 | 0.88 | HDAC1 (0.61) | ALDH1A1ABCG2KMT2AMEN1TSHR | |
| SCHEMBL10804929 | 0.88 | ALDH1A1 (0.55) | ALDH1A1ABCG2KMT2AMEN1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1155554-A | Preparation and use of novel reactive and processable fluororubbers | BAYER AG (DE) | 1997-07-30 | — | — | CN | claimed |
| US-20260125340-A1 | METHOD FOR PREPARING AMIDES FROM ESTERS | BASF SE (DE) | 2026-05-07 | — | — | US | disclosed |
| EP-4598900-A1 | METHOD FOR PREPARING AMIDES FROM ESTERS | BASF SE (DE) | 2025-08-13 | — | — | EP | disclosed |
| WO-2024074641-A1 | METHOD FOR PREPARING AMIDES FROM ESTERS | BASF SE (DE) | 2024-04-11 | — | — | WO | disclosed |
| CN-114276270-A | Synthesis method of compound with amido bond | 湖北文理学院 | 2022-04-05 | — | — | CN | disclosed |
| CN-107602620-B | Novel iridium-based complexes for ECL | 霍夫曼-拉罗奇有限公司 | 2020-08-28 | — | — | CN | disclosed |
| US-10227366-B2 | Bis-iridium-complexes for manufacturing of ECL-labels | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2019-03-12 | — | — | US | disclosed |
| US-10227366-B2 | Bis-iridium-complexes for manufacturing of ECL-labels | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2019-03-12 | — | — | US | disclosed |
| WO-2018194372-A1 | NOVEL SIRT 1 ACTIVATOR AND MEDICINAL USE THEREOF | 부산대학교 산학협력단 | 2018-10-25 | — | — | WO | disclosed |
| CN-104718218-B | Novel iridium basigamy compound for ECL | 霍夫曼-拉罗奇有限公司 | 2017-10-24 | — | — | CN | disclosed |
| EP-2673284-A1 | NEW IRIDIUM-BASED COMPLEXES FOR ECL | Roche Diagnostics GmbH (DE) | 2013-12-18 | — | — | EP | disclosed |
| US-20130323719-A1 | NEW IRIDIUM-BASED COMPLEXES FOR ECL | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2013-12-05 | — | — | US | disclosed |
| US-20130323857-A1 | NEW IRIDIUM-BASED COMPLEXES FOR ECL | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2013-12-05 | — | — | US | disclosed |
| CN-103370330-A | New iridium-based complexes for ECL | HOFFMANN LA ROCHE | 2013-10-23 | — | — | CN | disclosed |
| CN-103347888-A | Novel iridium-based complexes for ECL | HOFFMANN LA ROCHE | 2013-10-09 | — | — | CN | disclosed |
| WO-2012107420-A1 | NEW IRIDIUM-BASED COMPLEXES FOR ECL | ROCHE DIAGNOSTICS GMBH (DE) | 2012-08-16 | — | — | WO | disclosed |
| WO-2012107419-A1 | NEW IRIDIUM-BASED COMPLEXES FOR ECL | ROCHE DIAGNOSTICS GMBH (DE) | 2012-08-16 | — | — | WO | disclosed |
| WO-2012107419-A1 | NEW IRIDIUM-BASED COMPLEXES FOR ECL | ROCHE DIAGNOSTICS GMBH (DE) | 2012-08-16 | — | — | WO | disclosed |
| WO-2012107420-A1 | NEW IRIDIUM-BASED COMPLEXES FOR ECL | ROCHE DIAGNOSTICS GMBH (DE) | 2012-08-16 | — | — | WO | disclosed |
| CN-1155554-A | Preparation and use of novel reactive and processable fluororubbers | BAYER AG (DE) | 1997-07-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125340-A1 | METHOD FOR PREPARING AMIDES FROM ESTERS | CBR1, CBR3, SCO2 | ALDH1A1 117/4885ABCG2 1741/4885KMT2A 1928/4885 |
| US-10227366-B2 | Bis-iridium-complexes for manufacturing of ECL-labels | HLCS, PDCD2L, LAS1L | ALDH1A1 1757/4885ABCG2 3935/4885KMT2A 2954/4885 |
| US-20130323719-A1 | NEW IRIDIUM-BASED COMPLEXES FOR ECL | ALPL, LIG3, SOD3 | ALDH1A1 495/4885ABCG2 953/4885KMT2A 4397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.